Glen E Jorgensen

Title: Glen E Jorgensen: Innovator in Apheresis Technology

Introduction

Glen E Jorgensen is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of apheresis. With a total of 2 patents, Jorgensen's work focuses on improving the separation and yield of blood components.

Latest Patents

Jorgensen's latest patents include an innovative apheresis apparatus designed for separating an intermediate density component. This apparatus enhances the purity and yield of platelets extracted from donated whole blood through centrifugation. The device incorporates a centrifuge that separates whole blood into lower, intermediate, and higher density components. It features inlet and outlet ports that facilitate the recirculation of lower density blood components, optimizing the separation process without causing the intermediate density component to exit the centrifuge.

Another significant patent is the apheresis apparatus and method aimed at increasing the purity and yield of platelets. This method involves diluting whole blood in the centrifuge by recirculating fluid, such as plasma or saline, at varying flow rates. This technique improves the separation of intermediate density components, specifically platelets and white blood cells, enhancing the overall efficiency of the apheresis process.

Career Highlights

Glen E Jorgensen is associated with Haemonetics Corporation, a company renowned for its focus on blood management solutions. His work has contributed to advancements in medical technology, particularly in the field of blood component separation.

Collaborations

Jorgensen has collaborated with notable colleagues, including Allen Latham, Jr. and Theodoor H Sibinga. These partnerships have furthered the development of innovative solutions in the medical field.

Conclusion

Glen E Jorgensen's contributions to apheresis technology have significantly impacted the medical community. His innovative patents and collaborations reflect his commitment to improving blood management practices.